Your browser doesn't support javascript.
loading
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance.
Chatterji, Udayan; Garcia-Rivera, Jose A; Baugh, James; Gawlik, Katarzyna; Wong, Kelly A; Zhong, Weidong; Brass, Clifford A; Naoumov, Nikolai V; Gallay, Philippe A.
Affiliation
  • Chatterji U; Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Garcia-Rivera JA; Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Baugh J; Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Gawlik K; Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Wong KA; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Zhong W; Novartis Institutes for BioMedical Research, Emeryville, California, USA.
  • Brass CA; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Naoumov NV; Novartis Pharma AG, Basel, Switzerland.
  • Gallay PA; Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, California, USA gallay@scripps.edu.
Antimicrob Agents Chemother ; 58(6): 3327-34, 2014 Jun.
Article in En | MEDLINE | ID: mdl-24687498
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Cyclosporine / Hepatitis C / Viral Nonstructural Proteins / Hepacivirus / Hepatitis C, Chronic Type of study: Health_technology_assessment Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2014 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Cyclosporine / Hepatitis C / Viral Nonstructural Proteins / Hepacivirus / Hepatitis C, Chronic Type of study: Health_technology_assessment Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2014 Document type: Article Affiliation country: United States